Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Dermatophytic Onychomycosis Treatment Market to reach USD 8.66 billion by the end of 2030

Global Dermatophytic Onychomycosis Treatment Market Size Study & Forecast, by Product Type (Tablets, Nail Paints), By Route of Administration (Oral, Topical), By Type (Prescribed, Over-the-Counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels), and Regional Analysis, 2023-2030

Product Code: HLSHS-23870173
Publish Date: 15-11-2023
Page: 200

Global Dermatophytic Onychomycosis Treatment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.0% over the forecast period 2023-2030. Dermatophytic onychomycosis, also known as fungal nail infection, is a common condition caused by various types of fungi, primarily dermatophytes. It affects the nails, causing them to become discolored, brittle, and thickened. It constitutes approximately one-third of all fungal infections worldwide, with dermatophytes responsible for around 70%-80% of these cases. This growing prevalence has led to a rising need for medications designed to treat dermatophytic onychomycosis. The growing cases of diabetes, increasing awareness of dermatophytic onychomycosis and its treatment, as well as surging demand for topical treatments are the most prominent factors that are propelling the market demand across the globe.

In addition, the increasing aging population, coupled with the growing prevalence of onychomycosis globally are the leading factors that are accelerating the market growth during the estimated period. According to a 2020 article titled “High Prevalence of Mixed Infections in Global Onychomycosis,” the global prevalence of onychomycosis is estimated to be around 10%, with Trichophyton rubrum being the most commonly identified causative organism. Also, as per the NCBI article published in 2022, onychomycosis accounts for roughly half of all nail-related disorders and affects approximately 5.5% of the global population. Furthermore, data from the World Health Organization (WHO) in 2021 indicates that by 2030, approximately one in every six individuals globally will be aged 60 years or older. The number of individuals aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050, effectively doubling the global population of adults aged 60 and over to 2.1 billion by 2050. Moreover, the increasing government support for research and development, as well as the rising introduction of new and innovative treatments presents various lucrative opportunities over the forecast years. However, the high cost of treatment and the side effects of treatment are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Dermatophytic Onychomycosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising healthcare expenditure, increasing prevalence of onychomycosis, and diabetic patient populations are significantly propelling the market demand across the region.

Major market players included in this report are:
Bausch Health Companies Inc.
Pfizer Inc.
Galderma S.A
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc.
Cipla Inc.
Kaken Pharmaceuticals Co., Ltd.
Novan, Inc.
Anacor Pharmaceuticals, Inc.
Moberg Pharma AB

Recent Developments in the Market:
Ø In July 2021, Kaken Pharmaceutical and Almirall S.A. signed a license and distribution agreement to give Almirall the rights to produce and market the topical antifungal efinaconazole in Europe. The objective of this initiative is to increase the company’s geographic reach in Europe.
Ø In July 2021, Zydus Lifesciences secured approval from the U.S. FDA to market efinaconazole topical solution for the management of onychomycosis. This regulatory milestone bolstered the company’s presence and market position in the United States.
Global Dermatophytic Onychomycosis Treatment Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product Type, Route of Administration, Type, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Nail Paints

By Route of Administration:

By Type:
Over-the-Counter (OTC)

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Channels

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Dermatophytic Onychomycosis Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Dermatophytic Onychomycosis Treatment Market, by Product Type, 2020-2030 (USD Billion)
1.2.3. Dermatophytic Onychomycosis Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Dermatophytic Onychomycosis Treatment Market, by Type, 2020-2030 (USD Billion)
1.2.5. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Dermatophytic Onychomycosis Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dermatophytic Onychomycosis Treatment Market Dynamics
3.1. Dermatophytic Onychomycosis Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing awareness of dermatophytic onychomycosis and its treatment Rising aging population Growing prevalence of onychomycosis
3.1.2. Market Challenges High cost of treatment Side effects of treatment
3.1.3. Market Opportunities Increasing government support for research and development Rising introduction of new and innovative treatments
Chapter 4. Global Dermatophytic Onychomycosis Treatment Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Dermatophytic Onychomycosis Treatment Market, by Product Type
5.1. Market Snapshot
5.2. Global Dermatophytic Onychomycosis Treatment Market by Product Type, Performance – Potential Analysis
5.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
5.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
5.4.1. Tablets
5.4.2. Nail Paints
Chapter 6. Global Dermatophytic Onychomycosis Treatment Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Dermatophytic Onychomycosis Treatment Market by Route of Administration, Performance – Potential Analysis
6.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Topical
Chapter 7. Global Dermatophytic Onychomycosis Treatment Market, by Type
7.1. Market Snapshot
7.2. Global Dermatophytic Onychomycosis Treatment Market by Type, Performance – Potential Analysis
7.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
7.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
7.4.1. Prescribed
7.4.2. Over-the-Counter (OTC)
Chapter 8. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Channels
Chapter 9. Global Dermatophytic Onychomycosis Treatment Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Dermatophytic Onychomycosis Treatment Market, Regional Market Snapshot
9.4. North America Dermatophytic Onychomycosis Treatment Market
9.4.1. U.S. Dermatophytic Onychomycosis Treatment Market Product Type breakdown estimates & forecasts, 2020-2030 Route of Administration breakdown estimates & forecasts, 2020-2030 Type breakdown estimates & forecasts, 2020-2030 Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Dermatophytic Onychomycosis Treatment Market
9.5. Europe Dermatophytic Onychomycosis Treatment Market Snapshot
9.5.1. U.K. Dermatophytic Onychomycosis Treatment Market
9.5.2. Germany Dermatophytic Onychomycosis Treatment Market
9.5.3. France Dermatophytic Onychomycosis Treatment Market
9.5.4. Spain Dermatophytic Onychomycosis Treatment Market
9.5.5. Italy Dermatophytic Onychomycosis Treatment Market
9.5.6. Rest of Europe Dermatophytic Onychomycosis Treatment Market
9.6. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Snapshot
9.6.1. China Dermatophytic Onychomycosis Treatment Market
9.6.2. India Dermatophytic Onychomycosis Treatment Market
9.6.3. Japan Dermatophytic Onychomycosis Treatment Market
9.6.4. Australia Dermatophytic Onychomycosis Treatment Market
9.6.5. South Korea Dermatophytic Onychomycosis Treatment Market
9.6.6. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market
9.7. Latin America Dermatophytic Onychomycosis Treatment Market Snapshot
9.7.1. Brazil Dermatophytic Onychomycosis Treatment Market
9.7.2. Mexico Dermatophytic Onychomycosis Treatment Market
9.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market
9.8.1. Saudi Arabia Dermatophytic Onychomycosis Treatment Market
9.8.2. South Africa Dermatophytic Onychomycosis Treatment Market
9.8.3. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bausch Health Companies Inc. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.3.2. Pfizer Inc.
10.3.3. Galderma S.A
10.3.4. GlaxoSmithKline plc
10.3.5. Janssen Pharmaceuticals, Inc.
10.3.6. Cipla Inc.
10.3.7. Kaken Pharmaceuticals Co., Ltd.
10.3.8. Novan, Inc.
10.3.9. Anacor Pharmaceuticals, Inc.
10.3.10. Moberg Pharma AB
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now